PLAU and ovarian cancer: In the present study, IMD-4482 inhibited in vitro cell adhesion to VN in PAI-1-positive ovarian cancer cells, followed by the inhibition of ERK and FAK phosphorylation through the dissociation of the PAI-1/uPA/uPAR complex from integrin αVβ3.